AustralianSuper Pty Ltd Buys New Shares in Molina Healthcare, Inc $MOH

AustralianSuper Pty Ltd bought a new position in shares of Molina Healthcare, Inc (NYSE:MOH) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 53,785 shares of the company’s stock, valued at approximately $10,292,000.

Several other large investors have also recently bought and sold shares of MOH. Norges Bank bought a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $212,113,000. Invesco Ltd. grew its stake in shares of Molina Healthcare by 25.9% in the second quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock valued at $477,109,000 after buying an additional 329,759 shares in the last quarter. Rakuten Investment Management Inc. acquired a new position in Molina Healthcare during the third quarter worth $56,592,000. Vaughan Nelson Investment Management L.P. bought a new stake in Molina Healthcare during the third quarter worth $52,813,000. Finally, Viking Global Investors LP acquired a new stake in Molina Healthcare in the second quarter valued at $79,665,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Trading Down 1.2%

Shares of NYSE:MOH opened at $184.74 on Friday. Molina Healthcare, Inc has a 12-month low of $133.40 and a 12-month high of $359.97. The business has a 50 day moving average of $170.23 and a 200-day moving average of $172.18. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. The stock has a market cap of $10.01 billion, a PE ratio of 11.44 and a beta of 0.49.

Wall Street Analyst Weigh In

MOH has been the subject of a number of analyst reports. Sanford C. Bernstein reissued an “outperform” rating and issued a $224.00 price objective on shares of Molina Healthcare in a research report on Tuesday, January 6th. TD Cowen downgraded Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price target on the stock. in a research report on Thursday, October 16th. Mizuho set a $220.00 price objective on Molina Healthcare in a research note on Friday, January 9th. Deutsche Bank Aktiengesellschaft set a $165.00 target price on Molina Healthcare in a research note on Friday, October 24th. Finally, Barclays increased their price target on Molina Healthcare from $144.00 to $164.00 and gave the company an “underweight” rating in a research note on Monday, January 5th. Three research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $193.47.

Insiders Place Their Bets

In other news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total transaction of $51,058.14. Following the completion of the sale, the director owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.10% of the stock is owned by insiders.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.